These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs. Bountra C; Gale JD; Gardner CJ; Jordan CC; Kilpatrick GJ; Twissell DJ; Ward P Oncology; 1996 Jun; 53 Suppl 1():102-9. PubMed ID: 8692545 [TBL] [Abstract][Full Text] [Related]
7. Emesis and anti-emesis. Naylor RJ; Rudd JA Cancer Surv; 1994; 21():117-35. PubMed ID: 8564988 [TBL] [Abstract][Full Text] [Related]
9. Controlling cancer chemotherapy-induced emesis. An update. Seynaeve C; De Mulder PH; Verweij J; Gralla RJ Pharm Weekbl Sci; 1991 Oct; 13(5):189-97. PubMed ID: 1749707 [TBL] [Abstract][Full Text] [Related]
10. [Olanzapine use in cancer patients for refractory vomiting]. Shinjo T; Okada M Gan To Kagaku Ryoho; 2006 Mar; 33(3):349-52. PubMed ID: 16531716 [TBL] [Abstract][Full Text] [Related]
11. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment]. Longo F; Mansueto G Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022 [No Abstract] [Full Text] [Related]
12. Don't overlook emesis not caused by chemotherapy. J Support Oncol; 2006 Feb; 4(2):80-1. PubMed ID: 16502523 [No Abstract] [Full Text] [Related]
13. Antiemetics in children receiving cancer chemotherapy. Billett AL; Sallan SE Support Care Cancer; 1994 Sep; 2(5):279-85. PubMed ID: 8000723 [TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods. Mahesh R; Perumal RV; Pandi PV Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895 [TBL] [Abstract][Full Text] [Related]
15. Practical management of chemotherapy-induced nausea and vomiting. Wiser W; Berger A Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344 [TBL] [Abstract][Full Text] [Related]
16. Emesis as a critical problem in chemotherapy. Laszlo J; Lucas VS N Engl J Med; 1981 Oct; 305(16):948-9. PubMed ID: 7278899 [No Abstract] [Full Text] [Related]
17. 5-HT3-receptor antagonists in the control of delayed-onset emesis. Gridelli C Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112 [TBL] [Abstract][Full Text] [Related]
18. Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper. Tyers MB Br J Cancer Suppl; 1992 Dec; 19():S12-3. PubMed ID: 1467194 [No Abstract] [Full Text] [Related]
19. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development. Rizk AN; Hesketh PJ Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396 [TBL] [Abstract][Full Text] [Related]